Could OrganiGram Double Again by 2022?
It’s more likely than it sounds.
Oxygen plant makers suffer from key component shortages
Need for policy corrections from the government to ensure smooth supply, say Industry players
3 Best Growth Stocks to Buy Right Now
It’s the perfect time to snatch up these incredible stocks.
SP Accure Labs launches Amphotericin-B-Emulation drug for treatment of black fungus
This new drug will be offered in the market within a week at ₹5,400 per unit
Is Amazon Becoming a Healthcare Company?
Amazon has set its sights on the $4 trillion U.S. healthcare market.
Phillips 66: 4.0% Yield With Lots Of Upside
Phillips 66 is coming out of its toughest year Read more to read our review of the business, improving market conditions, dividend strength, valuation, and risks….
A hedge fund chief who oversees $1.7 billion unloads on the ‘lockdown traders’ who helped push stock valuations to historically absurd levels — and warns a drop of at least 60% is on the cards
Summary List PlacementMark Yusko doesn’t beat around the bush when talking about his market outlook.Stocks are due for a 60% pullback or more to reach what would…
It’s been 40 years since the first reported cases of AIDS. While treatments have come a long way, a vaccine remains elusive.
The parallels between AIDS/HIV and COVID-19 and the virus that causes it are stark. But the differences are striking, too.
Schneider National Stock Appears To Be Fairly Valued
The stock of Schneider National (NYSE:SNDR, 30-year Financials) appears to be fairly valued, according to GuruFocus Value calculation.
GaryVee and Mark Cuban on How History Has Already Proven That NFTs Are Here To Stay
Today’s episode is a segment from, “Episode 22: Marketing For The Now” where Mark Cuban and I sat down to talk about our long history with innovative technology,…